Page 2 - CIRN-AR-2015-PRESS.indd
P. 2
Table of Contents About the Canadian
1 Letter from CIRN Management Immunization Research
Committee
Network (CIRN)
2 CIRN Principal Investigators
CIRN Networks CIRN is in large part the continuation of the successful PHAC/
3 Clinical Trials Network
4 Canadian National Vaccine Safety CIHR Infl uenza Research Network (PCIRN), formed in 2009
Network through a pandemic infl uenza research funding opportunity.
5 Serious Outcomes Surveillance Network
6 Provincial Collaborative Network In late 2013, CIHR presented a grant opportunity to researchers
7 Special Immunization Clinics Network
8 Reference Laboratory Network in Canada interested in vaccine evaluative research. A national
Social Sciences and Humanities Network group of PCIRN and other vaccine researchers responded to
Modeling and Economics Research the request for application and additional collaborators were
Network
solicited; shortly after, the proposed Canadian Immunization
9 PCIRN Wrap Up Message and Research Network (CIRN) was formed. In July 2014, the
Reports
CIRN application was approved by CIHR. Plans were made to
transition from the infl uenza focused PCIRN to CIRN, a national
11 CIRN & PCIRN Trainees
network with a broader vaccine evaluation mandate.
Administration and Communication
13 CIRN Governance CIRN is funded by a three-year grant of $6.6 million from the
14 Financial Report
15 CIRN Co-Investigators and Contributors, Public Health Agency of Canada and CIHR, from June 2014 until
2014-2015 May 2017.
16 Publications, abstracts and presentations
CIRN is divided into eight sub-networks (or infrastructures), and
is managed through a collaborative process by the Principal
Investigators of each network. Together with the Nominated
Principal Investigator and 5 “at large” members, these Network
Leads make up the CIRN Management Committee.
COVER IMAGE REFERENCE:
Image from the RCSB PDB (www.rcsb.org) of PDB ID 3CSY (Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire,
E. O. (2008). Structure of the Ebola virus glycoprotein bound to a human survivor antibody. Nature, 454(7201), 177–182. doi:10.1038/
nature07082)
Canadian Immunization Research Network (CIRN)
1 Letter from CIRN Management Immunization Research
Committee
Network (CIRN)
2 CIRN Principal Investigators
CIRN Networks CIRN is in large part the continuation of the successful PHAC/
3 Clinical Trials Network
4 Canadian National Vaccine Safety CIHR Infl uenza Research Network (PCIRN), formed in 2009
Network through a pandemic infl uenza research funding opportunity.
5 Serious Outcomes Surveillance Network
6 Provincial Collaborative Network In late 2013, CIHR presented a grant opportunity to researchers
7 Special Immunization Clinics Network
8 Reference Laboratory Network in Canada interested in vaccine evaluative research. A national
Social Sciences and Humanities Network group of PCIRN and other vaccine researchers responded to
Modeling and Economics Research the request for application and additional collaborators were
Network
solicited; shortly after, the proposed Canadian Immunization
9 PCIRN Wrap Up Message and Research Network (CIRN) was formed. In July 2014, the
Reports
CIRN application was approved by CIHR. Plans were made to
transition from the infl uenza focused PCIRN to CIRN, a national
11 CIRN & PCIRN Trainees
network with a broader vaccine evaluation mandate.
Administration and Communication
13 CIRN Governance CIRN is funded by a three-year grant of $6.6 million from the
14 Financial Report
15 CIRN Co-Investigators and Contributors, Public Health Agency of Canada and CIHR, from June 2014 until
2014-2015 May 2017.
16 Publications, abstracts and presentations
CIRN is divided into eight sub-networks (or infrastructures), and
is managed through a collaborative process by the Principal
Investigators of each network. Together with the Nominated
Principal Investigator and 5 “at large” members, these Network
Leads make up the CIRN Management Committee.
COVER IMAGE REFERENCE:
Image from the RCSB PDB (www.rcsb.org) of PDB ID 3CSY (Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire,
E. O. (2008). Structure of the Ebola virus glycoprotein bound to a human survivor antibody. Nature, 454(7201), 177–182. doi:10.1038/
nature07082)
Canadian Immunization Research Network (CIRN)
